A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer
Clinical trial NCT03199677 · UNKNOWN
Trial details
- NCT number
- NCT03199677
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2018-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.